Navigation Links
Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

ancer

According to the American Cancer Society, 81,550 Americans will be diagnosed with head and neck cancer in 2007, including cancers of the tongue, the rest of the mouth, the salivary glands and inside the throat, the voice box, eye and orbit, thyroid and the lymph nodes in the upper neck. In addition, it is estimated that more than 12,900 Americans will die from this disease this year. Head and neck cancer most often affects people over the age of 50, and men are twice as likely to be diagnosed as women. The most common risk factors are tobacco and excessive alcohol use.

About ERBITUX(R) (Cetuximab)

ERBITUX is a monoclonal antibody (IgG1 Mab) designed to inhibit the function of a molecular structure expressed on the surface of normal and tumor cells called the epidermal growth factor receptor (EGFR, HER1, c-ErbB-1). In vitro assays and in vivo animal studies have shown that binding of ERBITUX to the EGFR blocks phosphorylation and activation of receptor-associated kinases, resulting in inhibition of cell growth, induction of apoptosis, and decreased matrix metalloproteinase and vascular endothelial growth factor production. In vitro, ERBITUX can mediate antibody-dependent cellular cytotoxicity (ADCC) against certain human tumor types. While the mechanism of ERBITUX' anti-tumor effect(s) in vivo is unknown, all of these processes may contribute to the overall therapeutic effect of ERBITUX. EGFR is part of a signaling pathway that is linked to the growth and development of many human cancers, including those of the head and neck, colon and rectum.

ERBITUX (Cetuximab), in combination with radiation therapy, is indicated for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck. ERBITUX as a single agent is indicated for the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck for whom prior platinum-based therapy has failed.

ERBITUX is indicated for
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:11/27/2014)... , Nov. 27, 2014  Javon Bea Mercy ... 19, faculty and staff at Janesville Craig High School ... from Mercy Health System physicians and Janesville ... Fire Departments and the Janesville ... Care Program, dedicated to providing schools and other organizations ...
(Date:11/27/2014)... November 27, 2014 Hovione announced ... (IND) Application with the U.S. Food and Drug Administration ... of developing improved drug delivery options for established drugs. ... a novel formulation using a new patented crystalline base ... most widely prescribed oral antibiotics for acne. Currently, there ...
(Date:11/27/2014)... , Nov. 27, 2014 ... to Academic Research - JIN Co., Ltd. will ... a market price of 500,000 yen or $5,000 (without tax ... software). The "ACADEMIC PACK" is a dedicated solution of "JINS ... capture and analyze deep data* generated by electrooculography and six-axis ...
Breaking Medicine Technology:Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3Hovione Files its First Investigational New Drug Application With the FDA 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3
... AMERICUS, Ga. , June 4 After ... the community, the staff of Phoebe Sumter Medical Center welcomed ... (MRI) system, compliments of Siemens Healthcare. The new MRI scanner ... donation after a tornado destroyed the hospital in 2007. State ...
... 4 St. Jude Medical Inc., a heart device ... the United States $3,898,300 to resolve ... two hospitals to secure heart-device business, the Justice Department announced ... be submitted to federal health care programs in violation of ...
Cached Medicine Technology:Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 2Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 3Heart Device Manufacturer in Minnesota and Hospitals in Ohio & Kentucky to Pay Nearly $4 Million to Resolve Fraud Allegations 2
(Date:11/27/2014)... is making every effort to offer more affordable but ... premier online supplier of elegant special occasion dresses and ... selection of sexy prom dresses today. In addition to ... beautiful styles in its product line. Click to buy ... “VogueQueen.com hopes to provide a truly unique shopping experience ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part of its monthly ... available to consumers. Mallory Sofastaii, a technology expert and reporter ... with viewers the company offers a cable case, iBed, and ... portability and functionality. A unique mobile company at IFA ... 5S has a portable USB charger built in. The certified ...
(Date:11/27/2014)... 27, 2014 Dr. Ronald Receveur, who has ... a few oral health tips before patients dig into the ... and New Albany affordable cosmetic dentistry, and his ... starch and sugar. While the staff wishes everyone a happy ... for how patients can enjoy a feast that is also ...
(Date:11/27/2014)... 27, 2014 HealthPostures, a ... equipment , has announced that it has entered ... Environments. The partnership will put HealthPostures' products into ... , In addition to having its products sold ... promotes HealthPostures' products with the business decision makers ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Allowing children to ... even during school, helps give children responsibility, ownership, boosts self-esteem, ... , Now, the real question is, how do ... a secret? According to a study published by Child Development ... have a dramatic effect on a child’s willingness to lend ...
Breaking Medicine News(10 mins):Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... (PHILADELPHIA) Tears in the aorta which affect thousands of people ... with a much less invasive technique that could dramatically ... study being directed by a vascular surgeon at Thomas ... method that could spare patients the trauma and risk ...
... generator of beliefs about the world. The capacity of our ... force for controlling both behavior and emotion, but the basis ... , In the January issue of Annals ... in the lab of Mark Cohen, a professor of psychiatry ...
... have been recognised in the inaugural National Health ... Hancock and Robert Parton, both from UQs Institute ... the School of Health &,Rehabilitation Sciences were among ... held tonight (Wednesday, December 12) in Canberra., The ...
... Reform package supported by 81 percent of Michigan adults, ... residents,support a package of reform measures proposed in the ... insurance market from,rate increases and set standard rating practices ... internal poll results made public today,by Blue Cross Blue ...
... up with community based, organizations and Babies "R" Us to help ... ... little ones, MERRILLVILLE, Ind., Dec. 12 With a traditional ... afternoon when,Anthem Blue Cross and Blue Shield hosts a community-wide baby ...
... Only one-third to one-half of those getting treatment reach ... (HealthDay News) -- Almost 75 percent of American adults ... have high blood pressure. , That,s the finding of ... data from 4,646 adults who took part in a ...
Cached Medicine News:Health News:Jefferson vascular surgeon heads national trial for torn aorta repair 2Health News:Jefferson vascular surgeon heads national trial for torn aorta repair 3Health News:UCLA study shows different areas of the brain respond to belief, disbelief and uncertainty 2Health News:UCLA study shows different areas of the brain respond to belief, disbelief and uncertainty 3Health News:UQ health and medical researchers recognized in awards 2Health News:Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 3Health News:High Blood Pressure Key Factor for Cardiovascular Disease 2
Anti-PR3 EIA Auto-Immune Markers 013-PR3-96 Proteinase...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
... Insulin-like growth factor 1 (IGF-1) is a polypeptide ... one of a number of related insulin-like growth ... approximately 50% sequence homology with proinsulin and has ... The peptide is growth hormone (GH) dependent to ...
Medicine Products: